Skip to main content
Equibles
MDLN logo

MDLN · Medline Inc. · Held by Funds

Track MDLN — free

Use MDLN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MDLN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$34.80 +0.10 (+0.29%)
Russell 1000 member Rebalance outlook locked
Customer concentration — key customers 74% of revenue

Key customers — 74% of revenue (the year ended December 31, 2025)

“for the year ended December 31, 2025, approximately $19.7 billion (or 69% of consolidated net sales and 74% of U.S. net sales) was from sales to member hospitals under contract with our largest GPOs: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P.”

Key customers — 69% of revenue (the year ended December 31, 2025)

“for the year ended December 31, 2025, approximately $19.7 billion (or 69% of consolidated net sales and 74% of U.S. net sales) was from sales to member hospitals under contract with our largest GPOs: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P.”

5 customers — 11.3% of revenue (the year ended December 31, 2025)

“For the year ended December 31, 2025, our top five U.S. customers represented approximately $3.2 billion (or 11.3%) of our net sales.”
View the 10-K filed Feb 25, 2026
Market Cap
$45.62B
Shares
1.31B
Volume · Sep 30 9.1M Avg daily vol (3M) 7.46M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Funds holding MDLN

380 fund positions
Fund Balance Value % of Fund Open
AMCAP Fund 16,002,681 $585,058,017 0.60%
Fidelity Contrafund 14,031,409 $553,398,771 0.31%
VANGUARD TOTAL STOCK MARKET INDEX FUND 12,406,857 $489,326,440 0.02%
VANGUARD MID-CAP INDEX FUND 8,466,394 $333,914,579 0.15%
Growth Fund of America 8,456,090 $309,154,650 0.09%
MFS Value Fund 6,590,752 $240,957,893 0.47%
Janus Henderson Forty Fund 5,908,950 $233,048,988 0.98%
Investment Co of America 5,210,238 $205,491,787 0.11%
VANGUARD EXTENDED MARKET INDEX FUND 4,615,761 $182,045,614 0.19%
MFS Growth Fund 4,163,316 $152,210,833 0.37%
VANGUARD VALUE INDEX FUND 3,715,953 $146,557,186 0.06%
BlackRock Mid-Cap Growth Equity Portfolio 3,734,925 $136,548,858 2.43%
Fidelity Puritan Fund 3,392,059 $124,013,677 0.37%
Capital World Growth & Income Fund 3,377,348 $123,475,843 0.08%
Janus Henderson Enterprise Fund 2,957,481 $116,643,051 0.52%
Fidelity Contrafund K6 2,948,399 $116,284,857 0.31%
GROWTH PORTFOLIO 2,776,624 $109,510,051 3.05%
VANGUARD U.S. GROWTH FUND 2,836,409 $103,699,113 0.22%
VANGUARD MID-CAP VALUE INDEX FUND 2,509,803 $98,986,630 0.27%
T. Rowe Price Mid-Cap Growth Fund, Inc. 2,438,449 $96,172,429 0.42%
MFS Mid Cap Growth Fund 2,411,142 $88,151,352 0.64%
Fidelity Extended Market Index Fund 2,076,456 $75,915,231 0.18%
Strategic Advisers Fidelity U.S. Total Stock Fund 2,049,707 $74,937,288 0.03%
iShares Russell Mid-Cap ETF 1,842,213 $72,656,881 0.13%
Invesco Main Street Fund 1,827,579 $71,787,303 0.62%
Fidelity Mid Cap Index Fund 1,699,749 $66,766,141 0.13%
Fidelity Blue Chip Growth Fund 1,698,871 $66,731,653 0.07%
MFS Mid Cap Value Fund 1,660,206 $65,478,525 0.38%
Janus Henderson Contrarian Fund 1,605,302 $63,313,111 1.15%
T. Rowe Price Blue Chip Growth Fund, Inc. 1,575,818 $62,150,262 0.10%
Growth-Income Fund 1,397,222 $55,106,436 0.12%
Fidelity Advisor Equity Growth Fund 1,497,108 $54,734,268 0.40%
VIP Growth Portfolio 1,387,600 $54,726,944 0.44%
Fidelity Advisor New Insights Fund 1,303,115 $51,394,856 0.18%
MidCap Fund 1,285,369 $50,489,294 0.22%
Transamerica Capital Growth 1,179,067 $46,313,752 4.09%
Select Medical Technology and Devices Portfolio 1,250,000 $45,700,000 1.54%
Fidelity Fund 1,143,600 $45,103,584 0.51%
Invesco Discovery Mid Cap Growth Fund 1,139,630 $44,764,666 0.66%
First Trust US Equity Opportunities ETF 1,058,710 $41,755,522 2.50%
Parnassus Mid Cap Fund 1,005,600 $39,660,864 1.57%
iShares Russell 1000 Value ETF 1,003,926 $39,594,841 0.05%
Fidelity Growth Company Fund 1,051,120 $38,428,947 0.04%
Morgan Stanley Discovery Portfolio 973,399 $38,390,857 3.07%
Select Health Care Portfolio 1,000,000 $36,560,000 0.63%
VIP Contrafund Portfolio 865,200 $34,123,488 0.11%
Janus Henderson Global Life Sciences Fund 851,191 $33,570,973 0.58%
BlackRock High Yield Portfolio 848,982 $33,483,850 0.12%
Fidelity Growth Discovery Fund 750,200 $29,587,888 0.44%
Fidelity Series Opportunistic Insights Fund 729,200 $28,759,648 0.19%
Showing 1–50 of 380 positions
Key facts CIK 2046386 CUSIP 58507V107 13F (30d) 10 filings 10 filers Visit website Investor relations